{"doi":"10.1158/2159-8290.cd-15-1545","title":"Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade","abstract":"<jats:title>Abstract</jats:title>\n                  <jats:p>Immune checkpoint blockade represents a major breakthrough in cancer therapy; however, responses are not universal. Genomic and immune features in pretreatment tumor biopsies have been reported to correlate with response in patients with melanoma and other cancers, but robust biomarkers have not been identified. We studied a cohort of patients with metastatic melanoma initially treated with cytotoxic T-lymphocyte–associated antigen-4 (CTLA4) blockade (n = 53) followed by programmed death-1 (PD-1) blockade at progression (n = 46), and analyzed immune signatures in longitudinal tissue samples collected at multiple time points during therapy. In this study, we demonstrate that adaptive immune signatures in tumor biopsy samples obtained early during the course of treatment are highly predictive of response to immune checkpoint blockade and also demonstrate differential effects on the tumor microenvironment induced by CTLA4 and PD-1 blockade. Importantly, potential mechanisms of therapeutic resistance to immune checkpoint blockade were also identified.</jats:p>\n                  <jats:p>Significance: These studies demonstrate that adaptive immune signatures in early on-treatment tumor biopsies are predictive of response to checkpoint blockade and yield insight into mechanisms of therapeutic resistance. These concepts have far-reaching implications in this age of precision medicine and should be explored in immune checkpoint blockade treatment across cancer types. Cancer Discov; 6(8); 827–37. ©2016 AACR.</jats:p>\n                  <jats:p>See related commentary by Teng et al., p. 818.</jats:p>\n                  <jats:p>This article is highlighted in the In This Issue feature, p. 803</jats:p>","journal":"Cancer Discovery","year":2016,"id":599239,"datarank":1.0381007256373027,"base_score":6.920671504248683,"endowment":6.920671504248683,"self_citation_contribution":1.0381007256373027,"citation_network_contribution":0.0,"self_endowment_contribution":1.0381007256373027,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1012,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":88472,"name":"Whijae Roh","orcid":"0000-0002-7395-9939","position":1,"is_corresponding":false},{"id":90418,"name":"Alexandre Reuben","orcid":"0000-0003-4510-0382","position":2,"is_corresponding":false},{"id":90465,"name":"Zachary A. Cooper","orcid":"0000-0003-1059-0940","position":3,"is_corresponding":false},{"id":90472,"name":"Christine N. Spencer","orcid":"0000-0002-1304-4390","position":4,"is_corresponding":false},{"id":90473,"name":"Peter A. Prieto","orcid":"0000-0003-3792-7355","position":5,"is_corresponding":false},{"id":523685,"name":"John P. Miller","orcid":"0000-0003-1493-1394","position":6,"is_corresponding":false},{"id":58751,"name":"Roland L. Bassett","orcid":"0000-0002-4534-2042","position":7,"is_corresponding":false},{"id":90416,"name":"Vancheswaran Gopalakrishnan","orcid":"0000-0002-8704-035X","position":8,"is_corresponding":false},{"id":320444,"name":"Khalida Wani","orcid":"0000-0002-2383-3908","position":9,"is_corresponding":false},{"id":1535774,"name":"Mariana Petaccia De Macedo","orcid":null,"position":10,"is_corresponding":false},{"id":90485,"name":"Jacob L. Austin-Breneman","orcid":null,"position":11,"is_corresponding":false},{"id":474707,"name":"Hong Jiang","orcid":"0000-0001-5099-868X","position":12,"is_corresponding":false},{"id":451224,"name":"Qing Chang","orcid":"0000-0001-7406-8479","position":13,"is_corresponding":false},{"id":90477,"name":"Sangeetha M. Reddy","orcid":"0000-0002-8401-1481","position":14,"is_corresponding":false},{"id":1535775,"name":"Wei-Shen Chen","orcid":null,"position":15,"is_corresponding":false},{"id":90468,"name":"Michael T. Tetzlaff","orcid":"0000-0001-7899-4138","position":16,"is_corresponding":false},{"id":1535776,"name":"Russell J. Broaddus","orcid":null,"position":17,"is_corresponding":false},{"id":72141,"name":"Michael A. Davies","orcid":"0000-0002-0977-0912","position":18,"is_corresponding":false},{"id":13483,"name":"Jeffrey E. Gershenwald","orcid":"0000-0003-4519-5369","position":19,"is_corresponding":false},{"id":69945,"name":"Lauren Haydu","orcid":null,"position":20,"is_corresponding":false},{"id":13708,"name":"Alexander J. Lazar","orcid":"0000-0002-6395-4499","position":21,"is_corresponding":false},{"id":90460,"name":"Sapna P. Patel","orcid":"0000-0003-1339-1517","position":22,"is_corresponding":false},{"id":72142,"name":"Patrick Hwu","orcid":"0000-0002-8293-1313","position":23,"is_corresponding":false},{"id":90459,"name":"Wen-Jen Hwu","orcid":"0000-0003-1674-0751","position":24,"is_corresponding":false},{"id":90456,"name":"Adi Diab","orcid":"0000-0002-0153-0244","position":25,"is_corresponding":false},{"id":90489,"name":"Isabella C. Glitza","orcid":null,"position":26,"is_corresponding":false},{"id":90490,"name":"Scott E. Woodman","orcid":"0000-0002-1157-6991","position":27,"is_corresponding":false},{"id":90481,"name":"Luis M. Vence","orcid":"0000-0003-3441-4095","position":28,"is_corresponding":false},{"id":226199,"name":"Ignacio I. Wistuba","orcid":"0000-0003-3365-6340","position":29,"is_corresponding":false},{"id":90491,"name":"Rodabe N. Amaria","orcid":"0000-0001-6876-278X","position":30,"is_corresponding":false},{"id":79458,"name":"Lawrence N. Kwong","orcid":"0000-0001-8370-1432","position":31,"is_corresponding":false},{"id":1535777,"name":"Victor Prieto","orcid":null,"position":32,"is_corresponding":false},{"id":35666,"name":"R. Eric Davis","orcid":null,"position":33,"is_corresponding":false},{"id":181776,"name":"Wencai Ma","orcid":null,"position":34,"is_corresponding":false},{"id":480145,"name":"Willem W. Overwijk","orcid":null,"position":35,"is_corresponding":false},{"id":4542,"name":"Arlene H. Sharpe","orcid":"0000-0002-9736-2109","position":36,"is_corresponding":false},{"id":422255,"name":"Jianhua Hu","orcid":"0000-0001-5637-304X","position":37,"is_corresponding":false},{"id":7944,"name":"P. Andrew Futreal","orcid":"0000-0001-8663-2671","position":38,"is_corresponding":false},{"id":104277,"name":"Jorge Blando","orcid":"0000-0003-3628-6656","position":39,"is_corresponding":false},{"id":90469,"name":"Padmanee Sharma","orcid":"0000-0003-4658-055X","position":40,"is_corresponding":false},{"id":90470,"name":"James P. Allison","orcid":"0000-0001-8980-5697","position":41,"is_corresponding":false},{"id":234743,"name":"Lynda Chin","orcid":null,"position":42,"is_corresponding":false},{"id":72152,"name":"Jennifer A. Wargo","orcid":"0000-0003-3438-7576","position":43,"is_corresponding":false},{"id":869050,"name":"Pei-Ling Chen","orcid":"0000-0001-6025-4318","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade","abstract":"UNLABELLED: Immune checkpoint blockade represents a major breakthrough in cancer therapy; however, responses are not universal. Genomic and immune features in pretreatment tumor biopsies have been reported to correlate with response in patients with melanoma and other cancers, but robust biomarkers have not been identified. We studied a cohort of patients with metastatic melanoma initially treated with cytotoxic T-lymphocyte-associated antigen-4 (CTLA4) blockade (n = 53) followed by programmed death-1 (PD-1) blockade at progression (n = 46), and analyzed immune signatures in longitudinal tissue samples collected at multiple time points during therapy. In this study, we demonstrate that adaptive immune signatures in tumor biopsy samples obtained early during the course of treatment are highly predictive of response to immune checkpoint blockade and also demonstrate differential effects on the tumor microenvironment induced by CTLA4 and PD-1 blockade. Importantly, potential mechanisms of therapeutic resistance to immune checkpoint blockade were also identified. SIGNIFICANCE: These studies demonstrate that adaptive immune signatures in early on-treatment tumor biopsies are predictive of response to checkpoint blockade and yield insight into mechanisms of therapeutic resistance. These concepts have far-reaching implications in this age of precision medicine and should be explored in immune checkpoint blockade treatment across cancer types. Cancer Discov; 6(8); 827-37. ©2016 AACR.See related commentary by Teng et al., p. 818This article is highlighted in the In This Issue feature, p. 803.","is_dataset_classified":null,"base_score":6.920671504248683,"endowment":6.920671504248683,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"27301722","pmcid":"PMC5082984","openalex_id":"https://openalex.org/W2435243879","authors":[],"funders":[{"funder_name":"NCI NIH HHS","grant_id":"T32 CA163185","title":null},{"funder_name":"NCI NIH HHS","grant_id":"P30 CA016672","title":null},{"funder_name":"NCI NIH HHS","grant_id":"T32 CA009599","title":null},{"funder_name":"NCI NIH HHS","grant_id":"K08 CA160692","title":null},{"funder_name":"NCI NIH HHS","grant_id":"T32 CA009666","title":null},{"funder_name":"NCI NIH HHS","grant_id":"U54 CA163125","title":null}],"total_grants":6,"fwci":42.9154,"citation_percentile":0.99869402,"influential_citations":0,"citation_trend":[{"year":2014,"count":1},{"year":2015,"count":1},{"year":2016,"count":13},{"year":2017,"count":101},{"year":2018,"count":86},{"year":2019,"count":98},{"year":2020,"count":146},{"year":2021,"count":205},{"year":2022,"count":101},{"year":2023,"count":93},{"year":2024,"count":84},{"year":2025,"count":57},{"year":2026,"count":22}],"oa_status":"green","license":null,"oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5082984","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5082984","host_type":"repository"},{"url":"https://doi.org/10.1158/2159-8290.cd-15-1545","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/27301722","host_type":"repository"}],"fields_of_study":["Cancer Immunotherapy and Biomarkers","Ferroptosis and cancer prognosis","Immunotherapy and Immune Responses"],"mesh_terms":["Antibodies, Monoclonal","Antineoplastic Agents","Biopsy","Humans","Immunohistochemistry","Melanoma","Neoplasms","Prognosis","Biomarkers","Cluster Analysis","T-Lymphocyte Subsets","Lymphocytes, Tumor-Infiltrating","Drug Resistance, Neoplasm","Gene Expression Profiling","Immunomodulation","B7-H1 Antigen","CTLA-4 Antigen","Programmed Cell Death 1 Receptor"],"keywords":["Blockade","Immune system","Immune checkpoint","Biology","Computational biology","Immunology","Cancer research","Immunotherapy","Receptor","Genetics"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-28T20:09:19.712852Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}